Certain clinical symptoms such as congenital heart defects, joint laxity, muscular hypotonia and bone cysts were reported by others in type-1 NF1 microdeletion patients (Mautner et al., 2010; Kehrer-Sawatzki et al., 2017), but these were not pronounced in our patients. This evidence concerns the gene SGCG and bone disorder.